MetLife Investment Management, LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 69 filers reported holding ALBIREO PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$213,161
+11.6%
9,8640.0%0.00%0.0%
Q3 2022$190,967
-2.5%
9,8640.0%0.00%0.0%
Q2 2022$195,899
-33.4%
9,8640.0%0.00%0.0%
Q1 2022$294,243
+97.5%
9,864
+54.2%
0.00%
+100.0%
Q4 2021$149,009
-25.4%
6,3980.0%0.00%
-50.0%
Q3 2021$199,618
-11.3%
6,3980.0%0.00%0.0%
Q2 2021$225,082
-0.2%
6,3980.0%0.00%0.0%
Q1 2021$225,530
-6.0%
6,3980.0%0.00%0.0%
Q4 2020$239,989
+12.4%
6,3980.0%0.00%0.0%
Q3 2020$213,501
+26.0%
6,3980.0%0.00%0.0%
Q2 2020$169,483
+119.7%
6,398
+35.8%
0.00%
+100.0%
Q1 2020$77,152
-35.6%
4,7130.0%0.00%0.0%
Q4 2019$119,804
+27.1%
4,7130.0%0.00%0.0%
Q3 2019$94,260
-38.0%
4,7130.0%0.00%
-50.0%
Q2 2019$151,947
+0.1%
4,7130.0%0.00%0.0%
Q1 2019$151,806
+31.3%
4,7130.0%0.00%
+100.0%
Q4 2018$115,610
-25.6%
4,7130.0%0.00%
-50.0%
Q3 2018$155,340
-7.0%
4,7130.0%0.00%0.0%
Q2 2018$167,0004,7130.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Perceptive Advisors 1,704,330$60,504,0001.59%
Birchview Capital, LP 38,000$1,349,0000.92%
Virtus ETF Advisers LLC 24,688$876,0000.77%
BVF INC/IL 220,000$7,810,0000.76%
SECTORAL ASSET MANAGEMENT INC 172,803$6,135,0000.69%
Chicago Capital, LLC 134,748$4,784,0000.39%
Artal Group S.A. 500,000$17,750,0000.38%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$25,432,0000.33%
Eversept Partners, LP 18,029$640,0300.29%
HEARTLAND ADVISORS INC 125,000$4,438,0000.29%
View complete list of ALBIREO PHARMA INC shareholders